Suppr超能文献

取代的1H-吲哚-2-甲酰胺作为CB1受体变构调节剂的构效关系

Structure-activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulators.

作者信息

Nguyen Thuy, German Nadezhda, Decker Ann M, Li Jun-Xu, Wiley Jenny L, Thomas Brian F, Kenakin Terry P, Zhang Yanan

机构信息

Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States.

Department of Pharmacology and Toxicology, University at Buffalo, the State University of New York, Buffalo, New York 14214, United States.

出版信息

Bioorg Med Chem. 2015 May 1;23(9):2195-2203. doi: 10.1016/j.bmc.2015.02.058. Epub 2015 Mar 7.

Abstract

A series of substituted 1H-indole-2-carboxamides structurally related to compounds Org27569 (1), Org29647 (2) and Org27759 (3) were synthesized and evaluated for CB1 allosteric modulating activity in calcium mobilization assays. Structure-activity relationship studies showed that the modulation potency of this series at the CB1 receptor was enhanced by the presence of a diethylamino group at the 4-position of the phenyl ring, a chloro or fluoro group at the C5 position and short alkyl groups at the C3 position on the indole ring. The most potent compound (45) had an IC₅₀ value of 79 nM which is ∼2.5 and 10 fold more potent than the parent compounds 3 and 1, respectively. These compounds appeared to be negative allosteric modulators at the CB1 receptor and dose-dependently reduced the Emax of agonist CP55,940. These analogs may provide the basis for further optimization and use of CB1 allosteric modulators.

摘要

合成了一系列与化合物Org27569(1)、Org29647(2)和Org27759(3)结构相关的取代1H-吲哚-2-甲酰胺,并在钙动员试验中评估了它们对CB1变构调节活性。构效关系研究表明,该系列化合物在CB1受体上的调节效力通过苯环4位上的二乙氨基、吲哚环C5位上的氯或氟基团以及吲哚环C3位上的短烷基的存在而增强。最有效的化合物(45)的IC₅₀值为79 nM,分别比母体化合物3和1强约2.5倍和10倍。这些化合物似乎是CB1受体的负性变构调节剂,并且剂量依赖性地降低了激动剂CP55,940的Emax。这些类似物可为CB1变构调节剂的进一步优化和应用提供基础。

相似文献

1
Structure-activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulators.
Bioorg Med Chem. 2015 May 1;23(9):2195-2203. doi: 10.1016/j.bmc.2015.02.058. Epub 2015 Mar 7.
2
Indole-2-carboxamides as allosteric modulators of the cannabinoid CB₁ receptor.
J Med Chem. 2012 Jun 14;55(11):5627-31. doi: 10.1021/jm201485c. Epub 2012 May 17.
9
7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands.
Bioorg Med Chem Lett. 2020 Nov 15;30(22):127501. doi: 10.1016/j.bmcl.2020.127501. Epub 2020 Aug 31.
10
Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling.
J Biol Chem. 2014 Feb 28;289(9):5828-45. doi: 10.1074/jbc.M113.478495. Epub 2013 Dec 23.

引用本文的文献

2
Covalent cannabinoid receptor ligands - structural insight and selectivity challenges.
RSC Med Chem. 2022 Apr 4;13(5):497-510. doi: 10.1039/d2md00006g. eCollection 2022 May 25.
4
Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids.
Bioorg Med Chem. 2021 Jul 1;41:116215. doi: 10.1016/j.bmc.2021.116215. Epub 2021 May 12.
5
Quantification of Receptor Occupancy by Ligand-An Understudied Class of Potential Biomarkers.
Cancers (Basel). 2020 Oct 13;12(10):2956. doi: 10.3390/cancers12102956.
6
Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric Modulators.
J Med Chem. 2019 Nov 14;62(21):9806-9823. doi: 10.1021/acs.jmedchem.9b01161. Epub 2019 Oct 24.
8
Selective modulation of the cannabinoid type 1 (CB) receptor as an emerging platform for the treatment of neuropathic pain.
Medchemcomm. 2019 Mar 18;10(5):647-659. doi: 10.1039/c8md00595h. eCollection 2019 May 1.
9
Exploring 6-Azaindole and 7-Azaindole Rings for Developing Cannabinoid Receptor 1 Allosteric Modulators.
Cannabis Cannabinoid Res. 2018 Dec 10;3(1):252-258. doi: 10.1089/can.2018.0046. eCollection 2018.
10
Translational potential of allosteric modulators targeting the cannabinoid CB receptor.
Acta Pharmacol Sin. 2019 Mar;40(3):324-335. doi: 10.1038/s41401-018-0164-x. Epub 2018 Oct 17.

本文引用的文献

1
Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats.
Pharmacol Res Perspect. 2014 Dec;2(6):e00069. doi: 10.1002/prp2.69. Epub 2014 Aug 24.
2
Effects of the cannabinoid CB₁ receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats.
Drug Alcohol Depend. 2014 Oct 1;143:251-6. doi: 10.1016/j.drugalcdep.2014.08.004. Epub 2014 Aug 17.
4
2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: a personal perspective.
J Med Chem. 2014 May 22;57(10):3891-911. doi: 10.1021/jm500220s. Epub 2014 May 1.
6
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569.
Behav Pharmacol. 2014 Apr;25(2):182-5. doi: 10.1097/FBP.0000000000000027.
7
Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling.
J Biol Chem. 2014 Feb 28;289(9):5828-45. doi: 10.1074/jbc.M113.478495. Epub 2013 Dec 23.
9
Profiling two indole-2-carboxamides for allosteric modulation of the CB1 receptor.
J Neurochem. 2013 Mar;124(5):584-9. doi: 10.1111/jnc.12115. Epub 2013 Jan 7.
10
CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity.
Mol Pharmacol. 2013 Feb;83(2):322-38. doi: 10.1124/mol.112.080879. Epub 2012 Nov 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验